GTS Securities’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,100
Closed -$48.6K 2164
2023
Q3
$48.6K Buy
+50,100
New +$48.6K ﹤0.01% 1273